Need an oil spill lawyer? We will fight for you!
› $150,000,000 verdict in personal injury case
A medication primarily used to treat men with prostate cancer has been associated with a slightly increased risk for diabetes, heart attack, stroke and sudden death. The findings are preliminary and are part of an ongoing analysis of several studies by the Food and Drug Administration (FDA).
Qualitest Pharmaceuticals, Inc., is recalling all lots of its Accusure Insulin Syringes, a type of syringe used to deliver insulin to patients with diabetes, because the syringes have been found to have needles that can detach from the syringe. When the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into the syringe, or remain in the skin after injection. The recall expands on an August recall of specific lots of Accusure Insulin Syringes for the same detaching needle issue, to cover all lots of Accusure Insulin Syringes.
The U.S. Food and Drug Administration has issued an alert for healthcare professionals and patients that a lot of ReliOn insulin syringes sold at Wal-Mart and Sam’s Club’s may be dangerously mislabeled. The manufacturer of the syringes, Tyco Healthcare Group LP, has voluntarily recalled the needles.
Diabetes patients who use the recalled syringes may inadvertently receive an overdose of up to 2.5 times the intended dose. Possible complications could include hypoglycemia and other serious side effects and death.
![[ Beasley Allen Law Firm Logo ]](http://www.southerninjurylawyer.com/wp-content/themes/system-unity/images/logo.png){kind=logo}